A minimally invasive procedure to determine whether patients with drug-resistant epilepsy are candidates for brain surgery is safer, more efficient, and leads to better outcomes than the traditional method, according to new research by The University of Texas Health Science Center at Houston (UTHealth). The study, published this week in JAMA Neurology, revealed that patients who had the […]
New funding will help one pediatric researcher bring personalized medicine closer to tuberous sclerosis patients. Laura Farach, MD, assistant professor of pediatrics, received grants from the Department of Defense (DoD) Military Medical Research and Development and the TS Alliance to develop a risk prediction model that can provide a personalized risk of seizures in patients […]
A clinical trial of a drug that researchers hope can prevent or delay the onset of epilepsy in children with tuberous sclerosis has begun at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).